Ironwood Pharmaceuticals Inc To Discuss The Topline Results Transcript
Welcome to the Ironwood Pharmaceuticals conference call to discuss the positive top line results from global Phase 3 trial, a once weekly absolute group tied in adults with short bowel syndrome with intestinal failure.
I would now like to welcome Tom McCourt, Chief Executive Officer, to begin the call. Tom, over to you.
Thanks, operator, and good morning, everyone. As the operator mentioned, I am Tom McCourt, Chief Executive Officer of Ironwood Pharmaceuticals, and I could not be more excited to join all of you to discuss the positive top line results from the pivotal Phase 3 STARS trial we announced earlier today. Before I begin, please take a moment to review our Safe Harbor statement as we will be making some forward-looking statements.
Today joining me today are Mike Shetzline, our Chief Medical Officer; Sravan Emany, our Chief Financial Officer; and Andrew Davis, our Chief Business Officer. Following our remarks, we'll open the call for a brief Q&A session.
We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
